Cartesian Therapeutics Inc
NASDAQ:RNAC

Watchlist Manager
Cartesian Therapeutics Inc Logo
Cartesian Therapeutics Inc
NASDAQ:RNAC
Watchlist
Price: 20.76 USD -0.1% Market Closed
Market Cap: 496m USD
Have any thoughts about
Cartesian Therapeutics Inc?
Write Note

P/E
Price to Earnings

-2.1
Current
-2.3
Median
23
Industry
Higher than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-2.1
=
Market Cap
496m USD
/
Net Income
-233.9m USD
All Countries
Close
Earnings Growth
US
Cartesian Therapeutics Inc
NASDAQ:RNAC
Average P/E: 223.9
Negative Multiple: -2.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -175 931.2 N/A
US
Abbvie Inc
NYSE:ABBV
69.4
412%
US
Amgen Inc
NASDAQ:AMGN
41.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -277.5
42%
US
Gilead Sciences Inc
NASDAQ:GILD
955
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -485.6 N/A
AU
CSL Ltd
ASX:CSL
34.4
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.6
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -56.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -128.3 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
-4.3
2-Years Forward
P/E
-5.8
3-Years Forward
P/E
-4.6

See Also

Discover More